Bold UK-wide campaign puts craft beer back at the centre of culture, celebrating better ingredients, better quality, skilled brewers, beer lovers and the big flavours that make craft worth choosing.

BrewDog consumers are back: sales across the brand’s top six off-trade retailers are up 2.87 times for Punk IPA vs last year’s volume for the same two-week period as the Under New Ownership and Choose Craft campaigns roll out across the UK.

BrewDog Choose Craft Banner

ELLON, Scotland, Oct. 07, 2026 (GLOBE NEWSWIRE) — BrewDog, a leader in U.K. craft beer and one of the world’s most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), is building commercial momentum under Tilray ownership, with a strong weekly sales snapshot and eight new on-trade partnerships spanning live entertainment, sport, pubs and hotels. Its UK-wide Choose Craft campaign will support that momentum, celebrating the quality, flavour and character that make craft beer worth choosing.

Choose Craft marks a confident new chapter for BrewDog and a rallying call for beer lovers across the UK. The campaign, by McCann Manchester, builds on the belief that quality still counts, the campaign celebrates the flavour, craft, creativity and attitude that set great beer apart, and signals BrewDog’s renewed momentum as it champions the category it helped define. The momentum is already showing at retail: since BrewDog began rolling out Choose Craft, EPOS data shows sales across its top six off-trade retailers are up 2.87 times for Punk IPA and Hazy Jane vs last year’s volume for the same two-week period as the Under New Ownership and Choose Craft campaigns roll out across the UK. Building on that momentum, new BrewDog craft beer innovation has secured more than 9,000 new distribution points across the UK. Alongside that retail momentum, BrewDog has secured eight new on-trade partnerships since Tilray took ownership, expanding its presence across live entertainment, sport, pubs and hotels. These include an Official Beer Partner agreement with Underbelly, bringing BrewDog’s full range to Edinburgh Fringe, Boulevard Soho, Skate in Leicester Square and Skate in Trafalgar Square, and a five-year Official Beer Partner agreement with Leicester Tigers. As well as some high profile on trade accounts such as Ladhar, Kew Green and Malones.

Choose Craft is rolling out now across the UK through bold, high-visibility placements, including murals in Manchester and Edinburgh, static and digital advertising across major national railway and underground stations, roadside locations and proximity advertising near key stockists. More than visibility, the campaign is designed to remind beer lovers why craft became a movement: quality ingredients, distinctive flavour, bold ideas and the details that make beer something people actively seek out, talk about and choose with pride.

BrewDog Choose Craft Banner 2

For BrewDog, the message is clear: the brand is back with purpose, energy and a sharper point of view. Following its Under New Ownership campaign, BrewDog is building on the spirit that made it iconic — uncompromising beer, a passionate community and a belief that craft should lead culture, not follow it.

John Beasley, Chief Marketing Officer, comments: “Choose Craft is a campaign with conviction. It is about putting quality, flavour and the craft beer community back in the spotlight — and reminding beer lovers across the UK why great beer is worth choosing. BrewDog is back with confidence, focus and momentum. We have always believed beer should have character, flavour and attitude. As the UK’s leading craft beer brand, we have a responsibility to champion quality, celebrate the brewers and beer lovers who built this movement, and give people every reason to choose craft.”

BrewDog is giving beer lovers more ways to join in and choose craft, including a grocery and BrewDog.com promotion on 10-packs of Lost Lager for £10, a Tesco-exclusive competition inviting shoppers to help create the next BrewDog beer, and a Scratch to Win mechanic across the on-trade, with experiential activations and customer moments designed to celebrate craft beer where people discover, buy and enjoy it.

Innovation That Raises the Bar for Craft

The campaign is also backed by a fresh wave of craft innovation from BrewDog. With discovery the #2 choice driver in craft after taste, BrewDog is keeping new flavours, formats and beer experiences front and centre. Premium 440ml cans account for 27% of craft sales and attract the category’s most engaged and highest-value shoppers, who spend three times as much as the average craft consumer. BrewDog’s latest beers, alongside the recent Liquid Visions launch, build on that appetite for discovery while reinforcing the brand’s commitment to quality, creativity and choice.

First up, West Coast Session IPA, Palm Break (330ml, 4% ABV), brings bright, easy-drinking craft refreshment with a West Coast edge. Light in body yet full in character, it balances lush fruit notes with a clean snap of bitterness, leaving a refreshing, resin-kissed afterglow.

BrewDog Palm BreakWith the stout market growing at +9.1%, Hazelnut Heist (440ml, 8% ABV) leans into continued consumer interest in rich, indulgent stout styles, particularly over the winter period. A decadent chocolate vanilla stout, it is loaded with roasted hazelnut, smooth vanilla and rich cocoa.

BrewDog HazelnutRaspberry Ripple New England IPA, Tripple Ripple (440ml, 6% ABV), is the latest collaboration with Mackie’s Ice Cream, bringing a playful, flavour-led twist to the craft category. It follows the phenomenal performance of the first Mackie’s collab, Two Scoops Stout, which was the #1 NPD brand in the craft category in the six months post-launch and recently won Gold at the World Beer Awards.

BrewDog MackiesFinally, Cloud Engine (440ml, 8% ABV) is a Double Dry Hopped New England IPA that delivers a flavour bomb of mango, passionfruit and ripe citrus, with a silky mouthfeel and none of the bitterness.

BrewDog Cloud Engine

About BrewDog  
BrewDog has always had one mission: making people as passionate about great beer as we are.
From iconic classics like Punk IPA, to crowd-pleasers like Lost Lager and Wingman, to boundary-pushing innovations like NanoDog, BrewDog has been brewing bold, distinctive beers since 2007.
Born in Scotland and built by a passionate community of beer lovers, BrewDog has grown into one of the world’s most recognizable craft beer brands, with a global presence spanning breweries, bars and distribution across multiple international markets. BrewDog’s future will continue to be shaped by the three things that matter most: People, Planet and Beer.

For more information, visit www.brewdog.com or follow @BrewDog on social media.  

About Tilray Brands 
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages. 

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms. 

Forward-Looking Statements
Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.   

Tilray Brands Contacts:
Media 
news@tilray.com

Investor Relations 
investors@tilray.com

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/537bf3f1-1e5d-4c0f-a2a7-372bd44bc76a
https://www.globenewswire.com/NewsRoom/AttachmentNg/e09104a1-231d-4281-a04b-ecc47e83d668
https://www.globenewswire.com/NewsRoom/AttachmentNg/a7acfb3e-7c16-4e3e-a72f-6b5dc40e0951
https://www.globenewswire.com/NewsRoom/AttachmentNg/05b2ee85-43f9-4f7a-a6b0-b9c131fcfec1
https://www.globenewswire.com/NewsRoom/AttachmentNg/50ae3053-9cd8-4ae5-aecb-55d019832f64
https://www.globenewswire.com/NewsRoom/AttachmentNg/48783ec8-0ee2-4c88-8a55-559a2c6dcf44

– Webcast scheduled for October 13, 2026, at 4:30 p.m. ET / 1:30 p.m. PT –

SAN DIEGO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Caspian Therapeutics, Inc. (“Caspian”) and Kura Oncology, Inc. (Nasdaq: KURA, “Kura”) today announced they will host an investor webcast on Tuesday, October 13 at 4:30 p.m. ET. On the call, management from the companies will provide details regarding the formation of Caspian and will also review KO-7246 data featured in an oral presentation at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting.

Virtual Investor Event

Caspian and Kura management will host a webcast and conference call on October 13, 2026 at 4:30 p.m. ET / 1:30 p.m. PT. The live webcast and replay will be available on www.kuraoncology.com under the Investors tab in the Events and Presentations section.

About Caspian Therapeutics

Caspian Therapeutics is pioneering menin-directed therapies in diabetes and other cardiometabolic diseases. Built on more than a decade of menin-inhibitor research at Kura Oncology, Caspian combines deep expertise in menin biology and medicinal chemistry with a development strategy focused on the requirements of diabetes and other cardiometabolic diseases.

Caspian’s lead compound, KO-7246, is a next-generation, highly selective and orally bioavailable menin inhibitor intended for metabolic applications and is currently in IND-enabling development. Caspian plans to evaluate KO-7246 in a Phase 1 program designed to assess its potential to restore functional β-cell capacity and endogenous insulin production in patients with diabetes. Caspian also plans to advance a second development candidate for additional cardiometabolic indications. To learn more, visit www.caspiantherapeutics.com. 

About Kura Oncology

Kura Oncology is a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Kura’s pipeline of small-molecule drug candidates is designed to target cancer signaling pathways and address high-need hematologic malignancies and solid tumors. Kura developed and is commercializing KOMZIFTI® (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit the Kura website and follow us on X and LinkedIn.

Contacts
Caspian Therapeutics
Robert Spencer, Ph.D.
rob@caspiantx.com 

Kura Oncology
Greg Mann
858-987-4046
gmann@kuraoncology.com

– Webcast scheduled for October 13, 2026, at 4:30 p.m. ET / 1:30 p.m. PT –

SAN DIEGO, Oct. 07, 2026 (GLOBE NEWSWIRE) — Caspian Therapeutics, Inc. (“Caspian”) and Kura Oncology, Inc. (Nasdaq: KURA, “Kura”) today announced they will host an investor webcast on Tuesday, October 13 at 4:30 p.m. ET. On the call, management from the companies will provide details regarding the formation of Caspian and will also review KO-7246 data featured in an oral presentation at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting.

Virtual Investor Event

Caspian and Kura management will host a webcast and conference call on October 13, 2026 at 4:30 p.m. ET / 1:30 p.m. PT. The live webcast and replay will be available on www.kuraoncology.com under the Investors tab in the Events and Presentations section.

About Caspian Therapeutics

Caspian Therapeutics is pioneering menin-directed therapies in diabetes and other cardiometabolic diseases. Built on more than a decade of menin-inhibitor research at Kura Oncology, Caspian combines deep expertise in menin biology and medicinal chemistry with a development strategy focused on the requirements of diabetes and other cardiometabolic diseases.

Caspian’s lead compound, KO-7246, is a next-generation, highly selective and orally bioavailable menin inhibitor intended for metabolic applications and is currently in IND-enabling development. Caspian plans to evaluate KO-7246 in a Phase 1 program designed to assess its potential to restore functional β-cell capacity and endogenous insulin production in patients with diabetes. Caspian also plans to advance a second development candidate for additional cardiometabolic indications. To learn more, visit www.caspiantherapeutics.com. 

About Kura Oncology

Kura Oncology is a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Kura’s pipeline of small-molecule drug candidates is designed to target cancer signaling pathways and address high-need hematologic malignancies and solid tumors. Kura developed and is commercializing KOMZIFTI® (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit the Kura website and follow us on X and LinkedIn.

Contacts
Caspian Therapeutics
Robert Spencer, Ph.D.
rob@caspiantx.com 

Kura Oncology
Greg Mann
858-987-4046
gmann@kuraoncology.com

ProVen Growth and Income VCT plc
Issue of Equity and Closure of Offer for Subscription
7 October 2026

The Directors of ProVen Growth and Income VCT plc announce an allotment on 7 October 2026 of ordinary shares of 1.6187p each (“Ordinary Shares”) pursuant to the offer for subscription that opened on 17 November 2025.

952,368 Ordinary Shares were allotted at an average price of 47.94p, based on the latest net asset value of 46.3p, being the net asset value per Ordinary Share as at 31 May 2026 adjusted for the dividend of 1.3p paid on 14 August 2026.

Application for the shares to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange’s market for listed securities will be made shortly.

These shares will rank pari passu with existing Ordinary Shares.

Following this allotment, the issued share capital and total voting rights of ProVen Growth and Income VCT plc is 328,971,725 Ordinary Shares.

Consistent with the announcement on 29 April 2026, the combined offer for subscription for the Company and ProVen VCT plc, which opened on 17 November 2025, closed on 30 September 2026 at 1pm BST.

Beringea LLP
Company Secretary
Telephone 020 7845 7820

-End-

ProVen Growth and Income VCT plc
Issue of Equity and Closure of Offer for Subscription
7 October 2026

The Directors of ProVen Growth and Income VCT plc announce an allotment on 7 October 2026 of ordinary shares of 1.6187p each (“Ordinary Shares”) pursuant to the offer for subscription that opened on 17 November 2025.

952,368 Ordinary Shares were allotted at an average price of 47.94p, based on the latest net asset value of 46.3p, being the net asset value per Ordinary Share as at 31 May 2026 adjusted for the dividend of 1.3p paid on 14 August 2026.

Application for the shares to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange’s market for listed securities will be made shortly.

These shares will rank pari passu with existing Ordinary Shares.

Following this allotment, the issued share capital and total voting rights of ProVen Growth and Income VCT plc is 328,971,725 Ordinary Shares.

Consistent with the announcement on 29 April 2026, the combined offer for subscription for the Company and ProVen VCT plc, which opened on 17 November 2025, closed on 30 September 2026 at 1pm BST.

Beringea LLP
Company Secretary
Telephone 020 7845 7820

-End-

ProVen VCT plc 
Issue of Equity and Closure of Offer for Subscription
7 October 2026

The Directors of ProVen VCT plc announce an allotment on 7 October 2026 of ordinary shares of 10p each (“Ordinary Shares”) pursuant to the offer for subscription that opened on 17 November 2025.

1,480,586 Ordinary Shares were allotted at an average price of 61.51p, based on the latest net asset value of 59.5p, being the net asset value per Ordinary Share as at 31 May 2026 adjusted for the dividend of 1.6p paid on 14 August 2026.

Application for the shares to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange’s market for listed securities will be made shortly.

These shares will rank pari passu with existing Ordinary Shares.

Following this allotment, the issued share capital and total voting rights of ProVen VCT plc is 300,056,220 Ordinary Shares.

Consistent with the announcement on 29 April 2026, the combined offer for subscription for the Company and ProVen Growth and Income VCT plc, which opened on 17 November 2025, closed on 30 September 2026 at 1pm BST.

Beringea LLP
Company Secretary
Telephone 020 7845 7820

-End-

ProVen VCT plc 
Issue of Equity and Closure of Offer for Subscription
7 October 2026

The Directors of ProVen VCT plc announce an allotment on 7 October 2026 of ordinary shares of 10p each (“Ordinary Shares”) pursuant to the offer for subscription that opened on 17 November 2025.

1,480,586 Ordinary Shares were allotted at an average price of 61.51p, based on the latest net asset value of 59.5p, being the net asset value per Ordinary Share as at 31 May 2026 adjusted for the dividend of 1.6p paid on 14 August 2026.

Application for the shares to be admitted to the Official List of the Financial Conduct Authority and to trading on the London Stock Exchange’s market for listed securities will be made shortly.

These shares will rank pari passu with existing Ordinary Shares.

Following this allotment, the issued share capital and total voting rights of ProVen VCT plc is 300,056,220 Ordinary Shares.

Consistent with the announcement on 29 April 2026, the combined offer for subscription for the Company and ProVen Growth and Income VCT plc, which opened on 17 November 2025, closed on 30 September 2026 at 1pm BST.

Beringea LLP
Company Secretary
Telephone 020 7845 7820

-End-

Additional orders underscore continued customer investment in SkyEdge IV, with deliveries scheduled over the next 12 months

PETAH TIKVA, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today announced that it has secured over $10 million in orders from a leading satellite operator for its multi-orbit SkyEdge IV platform. The systems are scheduled for delivery over the next 12 months.

The orders demonstrate ongoing demand for advanced connectivity services and will support the continued growth of high-capacity satellite networks serving a broad range of applications, including In-Flight Connectivity (IFC). Gilat’s SkyEdge IV platform provides the scale and operational efficiency needed to support increasing traffic volumes and diverse service offerings.

These orders underscore the continued adoption of SkyEdge IV by leading satellite operators and highlight the platform’s role in supporting large-scale network deployments. As operators expand existing services and introduce new capabilities, they continue to rely on proven ground segment technologies that can support their long-term business objectives.

“We are pleased to continue supporting this leading satellite operator as it advances its network initiatives,” said Ron Levin, President of Gilat Commercial Division. “These orders reaffirm the value of our SkyEdge IV platform and the confidence customers place in Gilat’s technology. Long-term customer relationships such as this one reflect our ability to deliver solutions that help operators enhance their networks and expand service offerings across IFC and other applications.”

About Gilat

Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications. With over 35 years of experience, we develop and deliver deep technology solutions for satellite, ground, and new space connectivity, offering next-generation solutions and services for critical connectivity across commercial and defense applications. We believe in the right of all people to be connected and are united in our resolution to provide communication solutions to all reaches of the world.

Together with our wholly owned subsidiaries Gilat Wavestream, Gilat DataPath, and Gilat Stellar Blu, we offer integrated, high-value solutions supporting multi-orbit constellations, Very High Throughput Satellites (VHTS), and Software-Defined Satellites (SDS) via our Commercial and Defense Divisions. Our comprehensive portfolio is comprised of a software-defined platform and modems, high-performance satellite terminals, advanced Satellite On-the-Move (SOTM) antennas and Electronically Steered Antennas (ESAs), highly efficient, high-power Solid State Power Amplifiers (SSPA) and Block Upconverters (BUC) and includes integrated ground systems for commercial and defense markets, field services, network management software, and cybersecurity services.

Gilat’s products and tailored solutions support multiple applications including government and defense, IFC and mobility, cellular backhaul, enterprise, aerospace and critical infrastructure clients all while meeting the most stringent service level requirements. For more information, please visit: https://www.gilat.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and can generally be identified by the use of forward-looking terminology such as “estimate,” “project,” “intend,” “expect,” “believe,” “anticipate,” “plan,” “may,” “will,” “seek,” “could,” “should,” or similar expressions. These forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements of Gilat to differ materially from those expressed in, or implied by, such statements. These risks and uncertainties include, among others, changes in general economic, market and business conditions; failure to maintain market acceptance of Gilat’s products; failure to timely develop and introduce new technologies, products and applications; rapid changes in the markets in which Gilat operates; increased competition, loss of market share or pressure on prices; loss of key OEM partners; inability to attract and retain qualified personnel; inability to protect proprietary technology; and risks associated with Gilat’s international operations and its location in Israel, including those arising from regional military conflicts and geopolitical instability. For additional information regarding these and other risks and uncertainties, please refer to Gilat’s filings with the U.S. Securities and Exchange Commission. Gilat undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Gilat Satellite Networks
Hagay Katz, Chief Products and Marketing Officer
PublicRelations@gilat.com

Additional orders underscore continued customer investment in SkyEdge IV, with deliveries scheduled over the next 12 months

PETAH TIKVA, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today announced that it has secured over $10 million in orders from a leading satellite operator for its multi-orbit SkyEdge IV platform. The systems are scheduled for delivery over the next 12 months.

The orders demonstrate ongoing demand for advanced connectivity services and will support the continued growth of high-capacity satellite networks serving a broad range of applications, including In-Flight Connectivity (IFC). Gilat’s SkyEdge IV platform provides the scale and operational efficiency needed to support increasing traffic volumes and diverse service offerings.

These orders underscore the continued adoption of SkyEdge IV by leading satellite operators and highlight the platform’s role in supporting large-scale network deployments. As operators expand existing services and introduce new capabilities, they continue to rely on proven ground segment technologies that can support their long-term business objectives.

“We are pleased to continue supporting this leading satellite operator as it advances its network initiatives,” said Ron Levin, President of Gilat Commercial Division. “These orders reaffirm the value of our SkyEdge IV platform and the confidence customers place in Gilat’s technology. Long-term customer relationships such as this one reflect our ability to deliver solutions that help operators enhance their networks and expand service offerings across IFC and other applications.”

About Gilat

Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT) is a leading global provider of satellite-based broadband communications. With over 35 years of experience, we develop and deliver deep technology solutions for satellite, ground, and new space connectivity, offering next-generation solutions and services for critical connectivity across commercial and defense applications. We believe in the right of all people to be connected and are united in our resolution to provide communication solutions to all reaches of the world.

Together with our wholly owned subsidiaries Gilat Wavestream, Gilat DataPath, and Gilat Stellar Blu, we offer integrated, high-value solutions supporting multi-orbit constellations, Very High Throughput Satellites (VHTS), and Software-Defined Satellites (SDS) via our Commercial and Defense Divisions. Our comprehensive portfolio is comprised of a software-defined platform and modems, high-performance satellite terminals, advanced Satellite On-the-Move (SOTM) antennas and Electronically Steered Antennas (ESAs), highly efficient, high-power Solid State Power Amplifiers (SSPA) and Block Upconverters (BUC) and includes integrated ground systems for commercial and defense markets, field services, network management software, and cybersecurity services.

Gilat’s products and tailored solutions support multiple applications including government and defense, IFC and mobility, cellular backhaul, enterprise, aerospace and critical infrastructure clients all while meeting the most stringent service level requirements. For more information, please visit: https://www.gilat.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and can generally be identified by the use of forward-looking terminology such as “estimate,” “project,” “intend,” “expect,” “believe,” “anticipate,” “plan,” “may,” “will,” “seek,” “could,” “should,” or similar expressions. These forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements of Gilat to differ materially from those expressed in, or implied by, such statements. These risks and uncertainties include, among others, changes in general economic, market and business conditions; failure to maintain market acceptance of Gilat’s products; failure to timely develop and introduce new technologies, products and applications; rapid changes in the markets in which Gilat operates; increased competition, loss of market share or pressure on prices; loss of key OEM partners; inability to attract and retain qualified personnel; inability to protect proprietary technology; and risks associated with Gilat’s international operations and its location in Israel, including those arising from regional military conflicts and geopolitical instability. For additional information regarding these and other risks and uncertainties, please refer to Gilat’s filings with the U.S. Securities and Exchange Commission. Gilat undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:

Gilat Satellite Networks
Hagay Katz, Chief Products and Marketing Officer
PublicRelations@gilat.com

CEO Saleel Awsare to discuss unmanned systems revenue growth, the company’s Blue UAS listing and its move up the value chain in defense unmanned systems

IRVINE, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) — Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure and resilient enterprise networks, today announced that President and CEO Saleel Awsare will attend the Association of the U.S. Army (AUSA) 2026 Annual Meeting and Exposition, Oct. 12–14 at the Walter E. Washington Convention Center in Washington, D.C., where he will hold meetings with investors, defense customers and partners.

“Our unmanned systems business went from a minimal contribution to $12.6 million in revenue in fiscal 2026, and customers are now asking for more than a compute module,” said Saleel Awsare, president and CEO of Lantronix. “That demand is moving Lantronix up the value chain toward integrated edge AI for autonomous systems, and AUSA puts us in front of the defense customers and partners driving it.”

Discussion topics will include:

  • Unmanned systems revenue of $12.6 million in fiscal 2026, up from a minimal contribution in fiscal 2025
  • The recent Blue UAS Framework listing of the Open-Q™ 8550CS System-on-Module, expanding access to U.S. defense and government programs
  • Demand tied to the Department of War’s $1.1 billion Drone Dominance Program, Europe and beyond-visual-line-of-sight (BVLOS) markets
  • Over 30 active engagements across defense, commercial, public safety and counter-UAS, with customers and partners including Sightline, AVT Australia, Swarmer and Unusual Machines

Investors interested in meeting with Lantronix during AUSA should contact Gateway Group at LTRX@gateway-grp.com.

About Lantronix
Lantronix Inc. (Nasdaq: LTRX) is a global leader in Edge AI and Industrial IoT solutions that power NDAA-compliant unmanned systems, critical infrastructure and resilient enterprise networks. It delivers intelligent computing, secure connectivity and remote management for mission-critical applications, enabling customers to optimize operations, enhance security and accelerate digital transformation. Its comprehensive portfolio of hardware, software and services powers applications ranging from mission-critical autonomous platforms and edge analytics for critical infrastructure to intelligent surveillance and secure network management. By bringing intelligence to the network edge, Lantronix helps organizations achieve efficiency, security and a competitive edge in today’s AI-driven world. For more information, visit the Lantronix website.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking statements within the meaning of federal securities laws, including, without limitation, statements concerning Lantronix’s participation in the AUSA 2026 Annual Meeting and Exposition, customer demand for integrated edge AI solutions for autonomous systems, and Lantronix’s positioning to capitalize on opportunities in the drone and defense technology markets. These forward-looking statements are based on our current expectations and are subject to substantial risks and uncertainties that could cause our actual results, future business, financial condition, or performance to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this news release. The potential risks and uncertainties include, but are not limited to, such factors as the effects of negative or worsening regional and worldwide economic conditions or market instability on our business, including effects on purchasing decisions by our customers; our ability to mitigate any disruption in our and our suppliers’ and vendors’ supply chains due to changes in U.S. or foreign government trade policies, including recently increased or future tariffs, a pandemic or other outbreaks, wars and recent conflicts in Europe, Asia and the Middle East, or other factors; future responses to and effects of public health crises; changes in defense spending or procurement programs, including the Drone Dominance Program; cybersecurity risks; changes in applicable U.S. and foreign government laws and regulations; our ability to successfully implement our acquisitions strategy or integrate acquired companies; difficulties and costs of protecting patents and other proprietary rights; the level of our indebtedness, our ability to service our indebtedness and the restrictions in our debt agreements; and any additional factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2026, filed with the Securities and Exchange Commission (the “SEC”) on Aug. 27, 2026, including in the section entitled “Risk Factors” in Item 1A of Part I of that report, as well as in our other public filings with the SEC. Additional risk factors may be identified from time to time in our future filings. In addition, actual results may differ as a result of additional risks and uncertainties about which we are currently unaware or which we do not currently view as material to our business. For these reasons, investors are cautioned not to place undue reliance on any forward-looking statements. The forward-looking statements we make speak only as of the date on which they are made. We expressly disclaim any intent or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by applicable law or the rules of the Nasdaq Stock Market LLC. If we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.

©2026 Lantronix, Inc. All rights reserved. Lantronix is a registered trademark. Other trademarks and trade names are those of their respective owners.

Investor Contact:  
Matt Glover and Greg Robles
Gateway Group, Inc.
LTRX@gateway-grp.com

Media Contact:
Diana Puckett
PRforLantronix@Bospar.com   

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.